top of page
News, Events and Updates
Search
Anavex’s Publication Supports Clinical Biomarker for ANAVEX®2-73 in Fragile X Syndrome
Jun 8, 2022
Anavex Life Sciences to Present at the H. C. Wainwright Global Investment Conference 2022
May 19, 2022
Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 Second Quarter Financial Results
May 10, 2022
Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tues. May 10, 2022
May 3, 2022
Anavex Life Sciences Announces Presentations at the IRSF Rett Syndrome Scientific Meeting
Apr 27, 2022
Anavex Life Sciences Invited to Present at a Neuro & Ophthalmology Conference
Apr 26, 2022
Anavex Life Sciences to Present at the Needham Virtual Healthcare Conference
Apr 7, 2022
Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit
Mar 28, 2022
Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from PDD study
Mar 15, 2022
Anavex Life Sciences to Participate in the Annual Needham Virtual Neuroscience Forum
Mar 9, 2022
Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP
Mar 4, 2022
7
8
9
10
11
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
